The peptide gained clinical interest because of a consistent pattern observed in rodent studies: BPC-157 accelerated healing of experimentally induced gastric ulcers, esophageal lesions, and intestinal anastomoses
Clinicians typically prescribe 250-500 mcg daily via oral administration (capsules or sublingual) for GI-targeted effects
For protocols that require unequal ratios, dose-escalation across one peptide while holding the other constant, or single-peptide arms, separate BPC-157 and TB-500 vials are the appropriate choice
This pentadecapeptide, derived from human gastric juice, demonstrates remarkable healing properties across multiple tissue types in preclinical research
While this function is important to prevent unregulated hypertrophy and ensure proper healing following injury, there are times when inhibiting myostatin could be of benefit
Cellulite and subcutaneous fat: the stubborn, often unwanted fat that resides just beneath our skin and gives rise to the dreaded orange peel appearance